NEWTON, Mass.--(BUSINESS WIRE)--Feb. 11, 2005--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate compounds that enable the targeted delivery of chemotherapy drugs to cancer cells, today announced that Carl L. Lueders has joined the management team as Chief Financial Officer.
